Endothelial dysfunction is a widely used term to describe an inability of endothelial cells for participating in vasodilation but also haemostasis, immune, and inflammatory reaction. Over past decades, an interdisciplinary switch in research on endothelial function could be observed. Primarily, its role was recognized in the variety of cardiovascular/metabolic disorders such as atherosclerosis, hypertension, heart failure, and diabetes mellitus. 2 -4 Recently, an association of endothelial dysfunction and cerebrovascular diseases has been reported.
1
Over past decades, an interdisciplinary switch in research on endothelial function could be observed. Primarily, its role was recognized in the variety of cardiovascular/metabolic disorders such as atherosclerosis, hypertension, heart failure, and diabetes mellitus. 2 -4 Recently, an association of endothelial dysfunction and cerebrovascular diseases has been reported. 5 -7 In clinical research, there are a number of techniques used for determination of endothelial dysfunction. 8 A widely used method in the clinical trials for determination of peripheral endothelial dysfunction is a non-invasive ultrasonographic imaging of endothelial-dependent flow-mediated dilatation of the brachial artery. 9 10 Endothelial dysfunction therefore is expressed as a percentage of post-stimulus artery dilatation diameter to baseline diameter. Still, there are some technical and interpretive limitations of this method and also a strong expertise is required for precise implementation. 11 12 Recently, a new method of peripheral arterial tonometry (PAT) in the fingertip, EndoPAT, was introduced. 13 This method is based on changes in artery digital pulse volume during reactive hyperaemia termed 'reactive hyperaemia index' (RHI) which is used as a surrogate for endothelial dysfunction. 14 The advantage of EndoPAT technology is that it could be easily applied to the patients; it has high reproducibility and is non-invasive. Recent studies revealed a reduced RHI in patients with coronary endothelial dysfunction, hypertension, smoking, hypercholesterolaemia, and ischaemic stroke suggesting decreased peripheral hyperaemic response and therefore provided an evidence of endothelial dysfunction. 7 14 15 In this issue, Bergströ m and colleagues 16 revealed evidence of peripheral endothelial dysfunction in the acute phase after aneurysmal subarachnoid haemorrhage (SAH). A vasospasm is a common complication after SAH that may occur up to several days later and is associated with poor clinical outcome. The authors aimed to identify a peripheral endothelial dysfunction in the early stage after SAH by EndoPAT in order to predict the development of cerebral vasospasm. This study revealed a decrease in RHI in patients in the first days after SAH and also an association with L-arginine/asymmetric dimethylarginine ratio, a marker of endothelial function. 17 Interestingly, in patients who died within 30 days after SAH, RHI was decreased compared with survivors. However, the authors did not find an association between RHI and established outcome predictors after SAH such as transcranial Doppler measurements of V MCA , plasma nitrite/nitrate level, or S-100B. They concluded that regulation of large cerebral blood vessels may occur by the nitrite/nitrate pathway and on the microvascular level via L-arginine/nitric oxide pathway what is in line with their previous findings. 18 However, further studies of pathophysiological mechanisms of central cerebral and peripheral endothelial activation are required. The number of clinical trials applying EndoPAT technology for functional vascular assessment is growing and its interdisciplinary applicability as well as easy-to-use technique suggest that EndoPAT might have a good perspective as a clinical diagnostic tool. To this end, EndoPAT as a diagnostic method needs to be better established with standard reference values from large clinical cohorts and strong background for data interpretation. We also need to learn how far we can transfer the data obtained from the peripheral vascular bed to Volume 112, Number 2, February 2014 the global endothelial function. However, a development of new (alternative) strategies for the diagnostics and treatment of endothelial dysfunction in various diseases is required.
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